DE-ERSRGs-chemical interactive network. by Wan-Jing Zhen (20427813)

Barbie audit data. by Cylie Williams (3446018)

“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”

The FEET system of barbie categorisation. by Cylie Williams (3446018)

“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”

Optimized TMS produces high-quality DNA methylation data across a range of plexing strategies, input amounts, and protocol modifications. by Amy Longtin (21409957)

S1 Graphical abstract - by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The top 10 hub targets. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

Original images for blots and gels requirements. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The top 10 active ingredients. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The flow chart. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The active ingredients in RB-HMM. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

Brg1 inhibition reduces KSHV lytic reactivation. by Praneet Kaur Sandhu (21156149)

Poly (I:C) intervention presented significantly beneficial on the liver lesion, liver inflammation and biliary injury caused by <i>C</i>. by Yuru Wang (846969)

Amx that only possesses the highly conserved TM2 domain is a potent inhibitor of Notch signaling. by Jose L. Salazar (3233190)

“…A 3xHA epitope (grey hexagon) was inserted after a predicted signal sequence (SS, blue box). …”

<i>Smp_248100</i> is specifically required for vitellaria maturation following pairing with a male worm. by Jipeng Wang (419413)

“…<p>(A) qPCR showing decreased <i>Smp_248100</i> transcript levels in <i>Smp_248100(RNAi)</i> versus <i>control(RNAi)</i>. …”

Meta-analytical results of secondary outcomes. by Maria-Sophie Brueckle (13816408)

The relationship between experimental and predicted ΔΔG of ACE2 mutants and relative SARS-CoV-2 pseudotype infectivity reported by Shukla et al [38]. by Stuart A. MacGowan (11326845)

Study characteristics. by Maria-Sophie Brueckle (13816408)

Forest plots of primary outcomes. by Maria-Sophie Brueckle (13816408)

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial by Kaiyun Chen (364164)

“…The follow-up ended in January 2010, and lasted for 7.7–106.4 months with a median of 47.6 months. TTR was significantly longer in the ¹²⁵I group (mean of 60.0 months vs. 36.7 months in the control). …”

Conceptual framework (Adapted from Abidin, 1995). by Rachel Brathwaite (767994)